pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-452 |
Genomic Coordinates | chrX: 151959628 - 151959712 |
Synonyms | MIRN452, hsa-mir-452, MIR452 |
Description | Homo sapiens miR-452 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-452-3p | ||||||||||||||||||
Sequence | 58| CUCAUCUGCAAAGAAGUAAGUG |79 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Array-cloned | ||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LRRC40 | ||||||||||||||||||||
Synonyms | dJ677H15.1 | ||||||||||||||||||||
Description | leucine rich repeat containing 40 | ||||||||||||||||||||
Transcript | NM_017768 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LRRC40 | |||||||||||||||||||||
3'UTR of LRRC40 (miRNA target sites are highlighted) |
>LRRC40|NM_017768|3'UTR 1 CATGGAGTTGCTTTATAACCCTTGTCATGTATTATTAACCCTGGTTAATTCTAAGGAGGATGTAACATTTGTTTTAGTAT 81 CATCTTAAAAGGTGATTATTGTAATTGATCTTGTAGTTTCCCAGTATCACCTACCTGTTGGTATAATTAGCCTGGGCCAT 161 ATTCACTGCCAGTAAATATTTTTACATTTTTATTTAAGATTTTTGTAAGGTGTTGTATACATTTGTAATGGTGATAACCA 241 CAATGTGTTCATACATTTGTTCTAAATGTTTTGCTTATGATTTATCCTGCTAACTTTCATTTTCTTATAGCAAGCAGTTT 321 TTTCAAAAATGAATTTTTATTTAATGTGGTTCAGTATTATAATAACAAAGCATTTTTGTAGAACTGGTTTTTTTTCTCAT 401 TTATTTTTGTATTCCATACAATGTGACCAATTGACTTGAATATGACTAGCCAGTTTCTATGTTTTTGTTAGATATAAAAT 481 TAAATCGAATTTTGTTGAATACTGTTCTTTGGCATTTAAAAAATAAGACCTTCTTATCTTGGGCCACATGTCAAAAGAAA 561 AAGGAAACAAAAATATATTAAAAATAAGACTTTTCATTACCCATGATAGGACTTTTGTGATATGGCTAATCTCAGTACAC 641 ATTTCAACTTAAAACCTTTTTATTTACAGCACCATAATTTTAAAATTTACTTGCAATCTTGGTAAGACTAAACTTGCAGT 721 GTTTTTCTAAAAGGGAATTTGATAGGTAAACTTGATTTAATAAAAATTAAATATCATTTTTGTTTACACCAAAATTATCA 801 GAAGTAGGTTGATTAGTCATTATAACACTTACCATATGATTCTATTAAGAAGTCAATTCAGTAGCATGTATATCAATTTA 881 TATAGATAGGTAGATAGCTTTTGGATGATTGAGGCATGCTTATATTATGAAAAAAATTGCTAATAAAGATAAATACTACA 961 TGTTCAGAATAAAAGTTACATTTTTCAAATATTGATTAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL35 |
Disease | MIMAT0001636 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020022. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020022 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL35 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000370952.3 | 3UTR | UCAAGCCUUAAGAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
87 hsa-miR-452-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT150000 | MIDN | midnolin | ![]() |
![]() |
2 | 10 | ||||||
MIRT330600 | ZWINT | ZW10 interacting kinetochore protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT358701 | SUB1 | SUB1 homolog, transcriptional regulator | ![]() |
![]() |
2 | 4 | ||||||
MIRT362854 | EIF4H | eukaryotic translation initiation factor 4H | ![]() |
![]() |
2 | 2 | ||||||
MIRT447215 | ATXN7 | ataxin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466655 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | ![]() |
![]() |
2 | 6 | ||||||
MIRT483979 | PANK1 | pantothenate kinase 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT485118 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488864 | AUTS8 | Autism, susceptibility to, 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492293 | SH2B3 | SH2B adaptor protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492976 | NCK2 | NCK adaptor protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497410 | LRRC40 | leucine rich repeat containing 40 | ![]() |
![]() |
2 | 2 | ||||||
MIRT511143 | MRPL17 | mitochondrial ribosomal protein L17 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512650 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513017 | NSFL1C | NSFL1 cofactor | ![]() |
![]() |
2 | 6 | ||||||
MIRT520445 | TSPAN2 | tetraspanin 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT527995 | NDNF | neuron derived neurotrophic factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT528667 | PDE4DIP | phosphodiesterase 4D interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT533512 | TRIM71 | tripartite motif containing 71 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537404 | FBXO47 | F-box protein 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538161 | DCP2 | decapping mRNA 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539124 | ARHGEF17 | Rho guanine nucleotide exchange factor 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540666 | MIS18A | MIS18 kinetochore protein A | ![]() |
![]() |
2 | 4 | ||||||
MIRT542948 | GDF11 | growth differentiation factor 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547534 | MAML3 | mastermind like transcriptional coactivator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559033 | C20orf24 | chromosome 20 open reading frame 24 | ![]() |
![]() |
2 | 4 | ||||||
MIRT559554 | ARF6 | ADP ribosylation factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570177 | RCBTB1 | RCC1 and BTB domain containing protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573149 | ITGA9 | integrin subunit alpha 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575849 | Rab1 | RAB1A, member RAS oncogene family | ![]() |
1 | 1 | |||||||
MIRT611034 | RRP1B | ribosomal RNA processing 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT616281 | HMGB1 | high mobility group box 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618372 | PRKG2 | protein kinase, cGMP-dependent, type II | ![]() |
![]() |
2 | 2 | ||||||
MIRT619540 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622303 | SGIP1 | SH3 domain GRB2 like endophilin interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622590 | PRRG4 | proline rich and Gla domain 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624441 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637089 | KLRD1 | killer cell lectin like receptor D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639084 | ADCYAP1 | adenylate cyclase activating polypeptide 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639334 | NINJ1 | ninjurin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639798 | EIF3E | eukaryotic translation initiation factor 3 subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT640851 | RAB3B | RAB3B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT641628 | KIAA1244 | ARFGEF family member 3 | ![]() |
1 | 1 | |||||||
MIRT642634 | EPPIN | epididymal peptidase inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT643053 | EPPIN-WFDC6 | EPPIN-WFDC6 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT643416 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | ![]() |
![]() |
2 | 2 | ||||||
MIRT645586 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT647393 | FAM181B | family with sequence similarity 181 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT649411 | CDC14B | cell division cycle 14B | ![]() |
![]() |
2 | 2 | ||||||
MIRT649477 | CLDN16 | claudin 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651307 | ZDHHC20 | zinc finger DHHC-type containing 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651387 | ZBTB16 | zinc finger and BTB domain containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653411 | SLC7A2 | solute carrier family 7 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654084 | RSPH4A | radial spoke head 4 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT654613 | PTPRM | protein tyrosine phosphatase, receptor type M | ![]() |
![]() |
2 | 2 | ||||||
MIRT655338 | PCP4L1 | Purkinje cell protein 4 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656173 | MRPL44 | mitochondrial ribosomal protein L44 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657272 | HS3ST3B1 | heparan sulfate-glucosamine 3-sulfotransferase 3B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657881 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659875 | CAPRIN1 | cell cycle associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662381 | ICA1L | islet cell autoantigen 1 like | ![]() |
![]() |
2 | 4 | ||||||
MIRT666308 | SLC22A3 | solute carrier family 22 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667274 | NAV1 | neuron navigator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667614 | LIMCH1 | LIM and calponin homology domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674242 | NUP62 | nucleoporin 62 | ![]() |
![]() |
2 | 4 | ||||||
MIRT690386 | PARP15 | poly(ADP-ribose) polymerase family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693402 | NUDT16 | nudix hydrolase 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702503 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708632 | STMN4 | stathmin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708839 | SCAND3 | zinc finger BED-type containing 9 | ![]() |
1 | 1 | |||||||
MIRT709016 | HSBP1 | heat shock factor binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709235 | RANGAP1 | Ran GTPase activating protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710885 | PARL | presenilin associated rhomboid like | ![]() |
![]() |
2 | 2 | ||||||
MIRT712262 | PPP1CB | protein phosphatase 1 catalytic subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT712573 | ATP2B4 | ATPase plasma membrane Ca2+ transporting 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715046 | PRPF38A | pre-mRNA processing factor 38A | ![]() |
![]() |
2 | 2 | ||||||
MIRT718905 | GALR1 | galanin receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719368 | FEM1A | fem-1 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT719495 | SEC24B | SEC24 homolog B, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT719601 | PRKX | protein kinase, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT719891 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720063 | ZNF449 | zinc finger protein 449 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721679 | CMTM4 | CKLF like MARVEL transmembrane domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721724 | VTI1A | vesicle transport through interaction with t-SNAREs 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT723370 | ZNF470 | zinc finger protein 470 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724941 | TXNL1 | thioredoxin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725302 | NLRC5 | NLR family CARD domain containing 5 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|